首页 | 本学科首页   官方微博 | 高级检索  
     

男性乳腺癌临床研究进展
引用本文:杨丽娟,王文珍,钱火红,黄叶莉. 男性乳腺癌临床研究进展[J]. 国际护理学杂志, 2006, 25(2): 85-87
作者姓名:杨丽娟  王文珍  钱火红  黄叶莉
作者单位:10037,北京,海军总医院急诊科;上海长海医院普外一科
摘    要:男性乳腺癌高峰年龄为50~60岁,发病主要与内分泌异常、遗传、损伤等因素有关,内源性激素可能起主要作用。首发症状以乳晕下及周围无痛性肿块为最常见,早期易侵犯胸肌及区域淋巴结,病理类型以浸润性导管癌最常见。受体阳性率高,腋窝淋巴结转移情况是最重要的预后指标,手术为首选治疗方法,辅以放化疗,受体阳性者加用激素治疗,晚期病例首选切除双侧睾丸治疗。

关 键 词:乳腺癌  男性  研究进展

The Progress of the Clinical Investigation into Male Breast Cancer
YANG Li-juan,WANG Wen-zhen,QIAN Hvo-hong,et al.. The Progress of the Clinical Investigation into Male Breast Cancer[J]. international journal of nursing, 2006, 25(2): 85-87
Authors:YANG Li-juan  WANG Wen-zhen  QIAN Hvo-hong  et al.
Affiliation:YANG Li-juan,WANG Wen-zhen,QIAN Hvo-hong,et al. Emergency of Naval Hospitas,Beijing 100037,China
Abstract:The median age was from 50 to 65 years old.The etiology remained poorly understood, but the imbalance of endocrineis the commonest factor. The first symptom usually is to discover the painless node and the main histological type is the invasive ductal carcinoma. The ER and PR receptors were positive in most patients,and the lymphatic axilla became the most important prognostic index. The optimal treatment for male breast cancer was ectomy combined with radiotherapy, chemotherapy and endocrintherapy.
Keywords:Breast cancer  Male  Progress
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号